DBDustin Baldridge

Dustin Baldridge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dustin Baldridge has a total of 478 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neurobehavioral Profiles and Clinical Consequences of MYT1L ‐Related Neurodevelopmental Disorder: Insights From the Brain Gene Registry

    by Jorge L. Granadillo, Levi Kaster, Virginia Lanzotti, Daleep Grewal, Allyson Schreiber, Anna M. Abbacchi, Christina A. Gurnett, Kristen L. Kroll, Dustin Baldridge, Heather C. Hazlett, et al.

    MYT1L ‐Related Neurodevelopmental Disorder ( MYT1L ‐NDD) is a rare autosomal dominant syndrome characterized by intellectual disability, global developmental delay, autism, and obesity. Despite growing recognition, prospective and systematic clinical phenotyping remains limited. Here, we present an exploratory analysis of data from 25 individuals with MYT1L ‐NDD enrolled in the Brain Gene Registry (BGR), a national platform integrating genetic, neurobehavioral, and clinical data. Neurobehavioral assessments were conducted using the Rapid Neurobehavioral Assessment Protocol (RNAP), including virtual adaptations of the Shipley, Developmental Profile‐4, ASEBA Child Behavior Checklist, and Vineland‐3. Diagnostic and medication data were extracted from structured electronic health records (EHR). MYT1L ‐NDD participants were compared to the broader BGR cohort. MYT1L ‐NDD participants exhibited pronounced impairments in nonverbal cognition and adaptive functioning, particularly in motor tasks, communication, and daily living skills. Behavioral assessments revealed elevated rates of autism symptoms, ADHD symptoms, behavioral conduct problems, oppositional defiance, and anxiety. EHR diagnosis data were available for 10 MYT1L ‐NDD participants. It showed frequent diagnoses of developmental delays, speech and language disorders, intellectual disability, gastrointestinal problems, and obesity. Medication data on five participants indicated common prescription of alpha‐2 adrenergic agonists and laxatives. This study provides the first prospective, multi‐source characterization of MYT1L ‐NDD. Findings expand our understanding of MYT1L ‐NDD phenotypes in a quantitative and systematic manner and support the value of registry‐based approaches for understanding rare neurodevelopmental disorders. Larger, longitudinal, age‐stratified studies are needed to further define MYT1L ‐NDD natural history and inform clinical care.

  • Open Access

    sortscore: Sort-seq MAVE scoring and visualization using Python

    by Caitlyn Chitwood, Emily Orr, Dustin Baldridge

    Summary: A growing number of tools enable the analysis of large variant libraries produced by multiplexed assays of variant effects (MAVEs). Experiments using fluorescent reporters and fluorescence-activated cell sorting sequencing (FACS-seq or Sort-seq) can coarsely quantify a given variant’s impact on phenotypes such as transcription activity. Existing bioinformatics tools for Sort-seq data broadly fall into two categories: methods that model a genotype-phenotype landscape to infer latent variant phenotypes, and methods that directly estimate individual variant scores from experimental binned counts. Within this second category, sortscore provides an activity score computed directly from observed counts without fitting a model, retaining the original experimental scale when bin median values are known. We present sortscore, a python package that incorporates a standard Sort-seq scoring method and normalization across sorted samples, technical replicates from separate sort times, and across oligos in tiled experiments. It also provides convenient heatmap visualizations. This software was used to analyze DMS experiments for the transcription factor GLI2. This work seeks to lower the barrier to entry and provide a clear starting point for scoring Sort-seq cell-based functional assays. This extends the availability of well-documented and reproducible data analysis protocols to a wider community employing MAVE techniques. Availability and implementation: The package can be downloaded from PyPI using the pip installer. The code is also freely accessible and available for reuse through a Public GitHub repository (MIT License). Installation instructions, documentation, and tutorials are accessible at the sortscore GitHub repository: https://github.com/dbaldridge-lab/sortscore. A snapshot of the code and data is available on Zenodo: https://doi.org/10.5281/zenodo.22119031.

  • Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy

    by Zitian Tang Bs, Sinem S. Ovunc, Ryo Iwase, Elle Mehinovic Msc, Simone Thomas Msc, Jenna Ulibarri Bs, Zefan Li Bs, Dustin Baldridge, Carlos Cruchaga, Menghan Liu Msc, et al.

    Objective: Biallelic intronic AAGGG repeat expansions in RFC1 cause cerebellar ataxia with neuropathy and vestibular areflexia syndrome and may also contribute to isolated sensory neuropathy. The clinical significance of both heterozygous and homozygous (biallelic) RFC1 expansions in more diverse patient populations remains unclear—partly due to the absence of accurate, user‐friendly computational pipelines specifically tailored for tandem repeat analysis. Methods: To discern the relationship between RFC1 expansions and idiopathic peripheral neuropathy (iPN), we performed whole‐genome sequencing (WGS) followed by polymerase chain reaction (PCR)‐based confirmation in a large, well‐characterized US cohort consisting of 788 patients with iPN (369 pure small fiber neuropathy (SFN), 266 sensorimotor, 144 pure sensory, and 9 pure motor). We developed an integrative pipeline combining ExpansionHunter Denovo and Expansion Hunter coupled with unsupervised clustering to reliably detect and genotype RFC1 expansions from short‐read WGS data, achieving 97.2% concordance with repeat‐primed PCR‐based validation. Results: Biallelic RFC1 expansions were present in only 1 out of 778 controls but present in 18 out of 788 (2.3%) patients with iPN (Fisher's exact p = 7 × 10 −5 ), including 6.9% (10/144) of pure sensory, 1.1% (4/369) of SFN, and 1.5% (4/266) of sensorimotor neuropathy. These data indicate that motor nerve involvement should not exclude patients from RFC1 repeat screening. Monoallelic expansions were observed at a nominally higher frequency in iPN than in controls (9.1% vs 7.2%), but this difference did not reach statistical significance (Fisher's exact p = 0.17). We also found no evidence of second mutations or expansions on the other allele among monoallelic carriers. Interpretation: Our approach provides a robust, cost‐effective method for detecting RFC1 expansions from WGS data. Our findings indicate that homozygous (biallelic) AAGGG repeat expansions in RFC1 contribute to development of iPN. Heterozygous expansions may also confer disease risk, but future studies are needed to assess this observation and explore any phenotypic differences with biallelic cases. ANN NEUROL 2026;100:95–108


  • Brain malformations and seizures by impaired chaperonin function of TRiC

    by Florian Kraft, Piere Rodriguez-Aliaga, Weimin Yuan, Lena Franken, Kamil Zajt, Dimah Hasan, Ting-Ting Lee, Elisabetta Flex, Andreas Hentschel, A. Micheil Innes, et al.

    Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”


  • Open Access

    The Brain Gene Registry: a data snapshot

    by Dustin Baldridge, Levi Kaster, Catherine Sancimino, Siddharth Srivastava, Sophie Molholm, Aditi Gupta, Inez Oh, Virginia Lanzotti, Daleep Grewal, Erin Rooney Riggs, et al.

    Monogenic disorders account for a large proportion of population-attributable risk for neurodevelopmental disabilities. However, the data necessary to infer a causal relationship between a given genetic variant and a particular neurodevelopmental disorder is often lacking. Recognizing this scientific roadblock, 13 Intellectual and Developmental Disabilities Research Centers (IDDRCs) formed a consortium to create the Brain Gene Registry (BGR), a repository pairing clinical genetic data with phenotypic data from participants with variants in putative brain genes. Phenotypic profiles are assembled from the electronic health record (EHR) and a battery of remotely administered standardized assessments collectively referred to as the Rapid Neurobehavioral Assessment Protocol (RNAP), which include cognitive, neurologic, and neuropsychiatric assessments, as well as assessments for attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Co-enrollment of BGR participants in the Clinical Genome Resource’s (ClinGen’s) GenomeConnect enables display of variant information in ClinVar. The BGR currently contains data on 479 participants who are 55% male, 6% Asian, 6% Black or African American, 76% white, and 12% Hispanic/Latine. Over 200 genes are represented in the BGR, with 12 or more participants harboring variants in each of these genes: CACNA1A, DNMT3A, SLC6A1, SETD5, and MYT1L. More than 30% of variants are de novo and 43% are classified as variants of uncertain significance (VUSs). Mean standard scores on cognitive or developmental screens are below average for the BGR cohort. EHR data reveal developmental delay as the earliest and most common diagnosis in this sample, followed by speech and language disorders, ASD, and ADHD. BGR data has already been used to accelerate gene-disease validity curation of 36 genes evaluated by ClinGen’s BGR Intellectual Disability (ID)-Autism (ASD) Gene Curation Expert Panel. In summary, the BGR is a resource for use by stakeholders interested in advancing translational research for brain genes and continues to recruit participants with clinically reported variants to establish a rich and well-characterized national resource to promote research on neurodevelopmental disorders.


  • Open Access

    Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signaling

    by Ronit Marom, Bo Zhang, Megan E. Washington, I-Wen Song, Lindsay C. Burrage, Vittoria C. Rossi, Ava S. Berrier, Anika Lindsey, Jacob Lesinski, Michael L. Nonet, et al.

    Background: Kinesin motor proteins transport intracellular cargo, including mRNA, proteins, and organelles. Pathogenic variants in kinesin-related genes have been implicated in neurodevelopmental disorders and skeletal dysplasias. We identifiedde novo, heterozygous variants inKIF5B, encoding a kinesin-1 subunit, in four individuals with osteogenesis imperfecta. The variants cluster within the highly conserved kinesin motor domain and are predicted to interfere with nucleotide binding, although the mechanistic consequences on cell signaling and function are unknown.Methods: To understand thein vivogenetic mechanism ofKIF5Bvariants, we modeled the p.Thr87Ile variant that was found in two patients in theC.elegansortholog,unc-116, at the corresponding position (Thr90Ile) by CRISPR/Cas9 editing and performed functional analysis. Next, we studied the cellular and molecular consequences of the recurrent p.Thr87Ile variant by microscopy, RNA and protein analysis in NIH3T3 cells, primary human fibroblasts and bone biopsy.Results: C.elegansheterozygous for theunc-116Thr90Ile variant displayed abnormal body length and motility phenotypes that were suppressed by additional copies of the wild type allele, consistent with a dominant negative mechanism. Time-lapse imaging of GFP-tagged mitochondria showed defective mitochondria transport inunc-116Thr90Ile neurons providing strong evidence for disrupted kinesin motor function. Microscopy studies in human cells showed dilated endoplasmic reticulum, multiple intracellular vacuoles, and abnormal distribution of the Golgi complex, supporting an intracellular trafficking defect. RNA sequencing, proteomic analysis, and bone immunohistochemistry demonstrated down regulation of the mTOR signaling pathway that was partially rescued with leucine supplementation in patient cells.Conclusion: We report dominant negative variants in theKIF5Bkinesin motor domain in individuals with osteogenesis imperfecta. This study expands the spectrum of kinesin-related disorders and identifies dysregulated signaling targets forKIF5Bin skeletal development.


  • Open Access

    Macrocephaly and developmental delay caused by missense variants in RAB5C

    by Klaas Koop, Weimin Yuan, Federico Tessadori, Wilmer R Rodriguez-Polanco, Jeremy Grubbs, Bo Zhang, Matt Osmond, Gail Graham, Sarah Sawyer, Erin Conboy, et al.

    Rab GTPases are important regulators of intracellular vesicular trafficking. RAB5C is a member of the Rab GTPase family that plays an important role in the endocytic pathway, membrane protein recycling and signaling. Here we report on 12 individuals with nine different heterozygous de novo variants in RAB5C. All but one patient with missense variants (n = 9) exhibited macrocephaly, combined with mild-to-moderate developmental delay. Patients with loss of function variants (n = 2) had an apparently more severe clinical phenotype with refractory epilepsy and intellectual disability but a normal head circumference. Four missense variants were investigated experimentally. In vitro biochemical studies revealed that all four variants were damaging, resulting in increased nucleotide exchange rate, attenuated responsivity to guanine exchange factors and heterogeneous effects on interactions with effector proteins. Studies in C. elegans confirmed that all four variants were damaging in vivo and showed defects in endocytic pathway function. The variant heterozygotes displayed phenotypes that were not observed in null heterozygotes, with two shown to be through a dominant negative mechanism. Expression of the human RAB5C variants in zebrafish embryos resulted in defective development, further underscoring the damaging effects of the RAB5C variants. Our combined bioinformatic, in vitro and in vivo experimental studies and clinical data support the association of RAB5C missense variants with a neurodevelopmental disorder characterized by macrocephaly and mild-to-moderate developmental delay through disruption of the endocytic pathway.


  • PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production

    by Frédéric Ebstein, Sébastien Küry, Victoria Most, Cory Rosenfelt, Marie-Pier Scott-Boyer, Geeske M. van Woerden, Thomas Besnard, Jonas Johannes Papendorf, Maja Studencka-Turski, Tianyun Wang, et al.

    A critical step in preserving protein homeostasis is the recognition, binding, unfolding, and translocation of protein substrates by six AAA-ATPase proteasome subunits (ATPase-associated with various cellular activities) termed PSMC1-6, which are required for degradation of proteins by 26 S proteasomes. Here, we identified 15 de novo missense variants in the PSMC3 gene encoding the AAA-ATPase proteasome subunit PSMC3/Rpt5 in 23 unrelated heterozygous patients with an autosomal dominant form of neurodevelopmental delay and intellectual disability. Expression of PSMC3 variants in mouse neuronal cultures led to altered dendrite development, and deletion of the PSMC3 fly ortholog Rpt5 impaired reversal learning capabilities in fruit flies. Structural modeling as well as proteomic and transcriptomic analyses of T cells derived from patients with PSMC3 variants implicated the PSMC3 variants in proteasome dysfunction through disruption of substrate translocation, induction of proteotoxic stress, and alterations in proteins controlling developmental and innate immune programs. The proteostatic perturbations in T cells from patients with PSMC3 variants correlated with a dysregulation in type I interferon (IFN) signaling in these T cells, which could be blocked by inhibition of the intracellular stress sensor protein kinase R (PKR). These results suggest that proteotoxic stress activated PKR in patient-derived T cells, resulting in a type I IFN response. The potential relationship among proteosome dysfunction, type I IFN production, and neurodevelopment suggests new directions in our understanding of pathogenesis in some neurodevelopmental disorders.


  • Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice

    by Sarah E. Sheppard, Laura Bryant, Rochelle N. Wickramasekara, Courtney Vaccaro, Brynn Robertson, Jodi Hallgren, Jason Hulen, Cynthia J. Watson, Victor Faundes, Yannis Duffourd, et al.

    Pathogenic variants in KMT5B , a lysine methyltransferase, are associated with global developmental delay, macrocephaly, autism, and congenital anomalies (OMIM # 617788). Given the relatively recent discovery of this disorder, it has not been fully characterized. Deep phenotyping of the largest ( n = 43) patient cohort to date identified that hypotonia and congenital heart defects are prominent features that were previously not associated with this syndrome. Both missense variants and putative loss-of-function variants resulted in slow growth in patient-derived cell lines. KMT5B homozygous knockout mice were smaller in size than their wild-type littermates but did not have significantly smaller brains, suggesting relative macrocephaly, also noted as a prominent clinical feature. RNA sequencing of patient lymphoblasts and Kmt5b haploinsufficient mouse brains identified differentially expressed pathways associated with nervous system development and function including axon guidance signaling. Overall, we identified additional pathogenic variants and clinical features in KMT5B -related neurodevelopmental disorder and provide insights into the molecular mechanisms of the disorder using multiple model systems.